NCT00440401 - TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

November 30, 2007

Conditions

HaemorrhageHaemostasisCardiovascular Surgery

Interventions

DRUG

fibrinogen (human) + thrombin (human)

DRUG

Standard haemostatic treatment in cardiovascular surgery

Any haemostatic fleece material without additional active coagulation stimulating compounds (primarily Surgicel®)

Trial Locations (1)

Nycomed, Roskilde